TB-500 (Thymosin Beta-4) 10mg (43aa)
TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide sequence.
TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide sequence.
Browse nearby entries from the full catalog, starting with Purchase Peptides.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantTB-500 (Thymosin Beta-4) is a 43-amino-acid peptide sequence. In animal models, it has been shown that Thymosin Beta-4 improves the growth of blood vessels, regulates wound healing, reduces inflammation, and reduces oxidative damage to the heart and central nervous system. Thymosin-beta-4 plays a role in protection, tissue repair, regeneration, and remodeling of injured or damaged tissue. It is also of great interest in anti-aging research.
Long-form guides and comparisons linked to this compound.
A detailed comparison of BPC-157 and TB-500 (Thymosin Beta-4) — two of the most researched healing peptides. Mechanisms, benefits, stac...
Everything about the Wolverine Stack — the popular BPC-157 and TB-500 peptide combination used for accelerated recovery. Protocols, dos...
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and...
Everything you need to know about BPC-157 — the gastric pentadecapeptide studied for gut healing, tendon repair, and tissue recovery. M...
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your...
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.